BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34220442)

  • 1. Rabbit PrP Is Partially Resistant to
    Angelli JN; Passos YM; Brito JMA; Silva JL; Cordeiro Y; Vieira TCRG
    Front Neurosci; 2021; 15():689315. PubMed ID: 34220442
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin binding confers prion stability and impairs its aggregation.
    Vieira TC; Cordeiro Y; Caughey B; Silva JL
    FASEB J; 2014 Jun; 28(6):2667-76. PubMed ID: 24648544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species.
    Vieira TC; Reynaldo DP; Gomes MP; Almeida MS; Cordeiro Y; Silva JL
    J Am Chem Soc; 2011 Jan; 133(2):334-44. PubMed ID: 21142149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates.
    Ellett LJ; Coleman BM; Shambrook MC; Johanssen VA; Collins SJ; Masters CL; Hill AF; Lawson VA
    Glycobiology; 2015 Jul; 25(7):745-55. PubMed ID: 25701659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
    Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
    J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
    Davenport KA; Henderson DM; Mathiason CK; Hoover EA
    J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the role of lipids in prion conversion and disease?
    Alves Conceição C; Assis de Lemos G; Barros CA; Vieira TCRG
    Front Mol Neurosci; 2022; 15():1032541. PubMed ID: 36704327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms.
    Bossers A; Belt PBGM ; Raymond GJ; Caughey B; de Vries R; Smits MA
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4931-6. PubMed ID: 9144167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of Cu2+-binding on oligomerization of human and rabbit prion proteins.
    Lin K; Yu Z; Yu Y; Liao X; Huang P; Guo C; Lin D
    Acta Biochim Biophys Sin (Shanghai); 2015 Oct; 47(10):842-50. PubMed ID: 26350098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification.
    Imamura M; Tabeta N; Kato N; Matsuura Y; Iwamaru Y; Yokoyama T; Murayama Y
    J Biol Chem; 2016 Dec; 291(51):26478-26486. PubMed ID: 27821590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting interactions between prion protein isoforms.
    Caughey B; Baron GS
    Biochem Soc Trans; 2002 Aug; 30(4):565-9. PubMed ID: 12196138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of divalent cations on elk prion protein fibril formation and stability.
    Samorodnitsky D; Nicholson EM
    Prion; 2018 Jan; 12(1):63-71. PubMed ID: 29310497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras.
    Kupfer L; Eiden M; Buschmann A; Groschup MH
    Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo.
    Piening N; Nonno R; Di Bari M; Walter S; Windl O; Agrimi U; Kretzschmar HA; Bertsch U
    J Biol Chem; 2006 Apr; 281(14):9373-84. PubMed ID: 16455657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cofactors influence the biological properties of infectious recombinant prions.
    Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
    Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating chronic wasting disease susceptibility in cervids using real-time quaking-induced conversion.
    Haley NJ; Rielinger R; Davenport KA; O'Rourke K; Mitchell G; Richt JA
    J Gen Virol; 2017 Nov; 98(11):2882-2892. PubMed ID: 29058651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decipher the mechanisms of rabbit's low susceptibility to prion infection.
    Yuan Z; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2013 Nov; 45(11):899-903. PubMed ID: 24041958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.